Showing results (111-120 of 1,494) with videos related to
Sort By:
Pageof 150
Journal of Clinical Pharmacology|January 7, 2026
Bioequivalence Assessment for Intranasal Rapid-Acting Drug ProductsZhijun Kevin Wang, Shein Chung Chow, Moses S S ChowStatistics in Medicine|August 31, 2012
Scientific considerations for assessing biosimilar productsShein-Chung Chow, Jun Wang, Laszlo Endrenyi, et al.Journal of Biopharmaceutical Statistics|March 11, 2011
Imputation method adjusted for covariates for nonrespondents in instruments with applicationsJuan Li, Eric M Chi, Chunyao Feng, et al.Journal of Biopharmaceutical Statistics|August 8, 2014
Scientific factors and current issues in biosimilar studiesShein-Chung Chow, Laszlo Endrenyi, Peter A Lachenbruch, et al.Journal of Biopharmaceutical Statistics|June 2, 2012
Analysis of time-to-event data with nonuniform patient entry and loss to follow-up under a two-stage seamless adaptive design with weibull distributionQingshu Lu, Siu-Keung Tse, Shein-Chung Chow, et al.Journal of Biopharmaceutical Statistics|February 26, 2010
On assessing bioequivalence using genomic data with model misspecificationQingshu Lu, Siu-Keung Tse, Shein-Chung Chow, et al.Journal of Biopharmaceutical Statistics|January 16, 2010
A comparison of moment-based and probability-based criteria for assessment of follow-on biologicsShein-Chung Chow, Tsung-Cheng Hsieh, Eric Chi, et al.Journal of Biopharmaceutical Statistics|January 16, 2010
Statistical methods for assessment of biosimilarity using biomarker dataShein-Chung Chow, Qingshu Lu, Siu-Keung Tse, et al.Therapeutic Innovation & Regulatory Science|March 3, 2025
A Proposed Confidence Ellipse Approach for Benefit-Risk Assessment in Clinical TrialsYinuo Zhang, Xiaofang Zhang, Peijin Wang, et al.Statistics in Medicine|August 31, 2012
Impact of variability on the choice of biosimilarity limits in assessing follow-on biologicsNan Zhang, Jun Yang, Shein-Chung Chow, et al.Pageof 150